You're viewing 1 of thousands of contract wins in our system
Members identify procurement patterns and decision makers. Track win rates, contract values, and renewal opportunities.
Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica® for Drug Discovery
Company Info
Company news
Mon, 02 Jun 2025 14:51:00 GMT
Preclinical CRO Market Generated Opportunities, Future Scope - openPR.com
Wed, 11 Dec 2024 08:00:00 GMT
Preclinical CRO Industry Assessment: Growth Opportunities and Strategies to 2033 - GlobeNewswire
Mon, 17 Feb 2025 08:00:00 GMT
Preclinical CRO Market Size Projected to Reach USD 13.14 Bn by 2034 - BioSpace
Wed, 28 May 2025 07:54:00 GMT
Preclinical CRO Market to Set Phenomenal Growth From 2025 to 2034 - openPR.com
Tue, 25 Feb 2025 08:00:00 GMT
U.S. Preclinical CRO Market Size to Surpass USD 4.66 Billion by 2034 - BioSpace
Thu, 03 Oct 2024 07:00:00 GMT
Global Preclinical CRO Market Size to Hit USD 21.48 billion by 2033 | Straits Research - GlobeNewswire
Wed, 05 Jun 2024 07:00:00 GMT
Charles River and Sanofi collab to replace animals with virtual controls in preclinical research - Fierce Biotech
Thu, 12 Oct 2023 15:27:19 GMT
Charles River Labs: Accelerating drug development as a digitally-enabled trusted partner - McKinsey & Company
Tue, 06 May 2025 07:00:00 GMT
Radiopharmaceutical Preclinical CRO Market Top Players - - openPR.com
Tue, 07 Jan 2025 08:00:00 GMT
Deciphex Secures $32.3M Series C to Address Global Pathology Shortage - Business Wire
Get deeper insights on Charles River Laboratories International's contracts
Direct contacts for procurement decision makers
AI alerts for renewal and expansion opportunities
Track competitive wins and procurement patterns
Used by teams at Oracle, Google, LinkedIn
Trends
Raised | Growth The data in the raised column shows reported funding for this location/industry over last 90 days. The data in the growth column indicates the % increase or decrease of the last 90 days vs. the previous 90 days. Please note: one or more large fundings, especially for a location/industry that doesn't historically receive much funding, can have a significant impact on the increase or decrease percentage. | |
---|---|---|
biotechnology | $9 B | -22.7% |
health care | $8 B | -31.4% |
pharmaceutical | $186.2 M | -83.3% |